Clomid 100mg (Clomiphene Citrate)

$11

Manufacturer: Cipla, India
Category: PCT (Post Cycle Therapy)
Substance: Clomiphene Citrate
Package: 10 tablets/strip

Description

Clomid 100mg Info

What is clomiphene?

Clomiphene is a non-steroidal fertility medicine. It causes the pituitary gland to release hormones needed to stimulate ovulation (the release of an egg from the ovary).

Clomiphene is used to cause ovulation in women with certain medical conditions (such as polycystic ovary syndrome) that prevent naturally occurring ovulation.

Clomiphene may also be used for purposes not listed in this medication guide.

Important information

Do not use clomiphene if you are already pregnant.

You should not use clomiphene if you have: liver disease, abnormal vaginal bleeding, an uncontrolled adrenal gland or thyroid disorder, an ovarian cyst (unrelated to polycystic ovary syndrome), or if you are pregnant.

SLIDESHOW

Multiple Sclerosis: What’s New in Treatment Options?

Before taking this medicine

You should not use clomiphene if you are allergic to it, or if you have:

abnormal vaginal bleeding;
an ovarian cyst that is not related to polycystic ovary syndrome;
past or present liver disease;
a tumor of your pituitary gland;
an untreated or uncontrolled problem with your thyroid or adrenal gland; or
if you are pregnant.
To make sure clomiphene is safe for you, tell your doctor if you have:

endometriosis or uterine fibroids.

Do not use clomiphene if you are already pregnant. Talk to your doctor if you have concerns about the possible effects of this medicine on a new pregnancy.

Clomiphene can pass into breast milk and may harm a nursing baby. This medication may slow breast milk production in some women. Tell your doctor if you are breast-feeding a baby.

Using clomiphene for longer than 3 treatment cycles may increase your risk of developing an ovarian tumor. Ask your doctor about your specific risk.

Fertility treatment may increase your chance of having multiple births (twins, triplets). These are high-risk pregnancies both for the mother and the babies. Talk to your doctor if you have concerns about this risk.

How should I take clomiphene?

Use clomiphene exactly as directed by your doctor. Follow all directions on your prescription label. Your doctor may occasionally change your dose to make sure you get the best results. Do not take this medicine in larger or smaller amounts or for longer than recommended.

Your doctor will perform medical tests to make sure you do not have conditions that would prevent you from safely using clomiphene.

Clomiphene is usually taken for 5 days, starting on the 5th day of your menstrual period. Follow your doctor’s instructions.

You will need to have a pelvic examination before each treatment cycle. You must remain under the care of a doctor while you are using this medicine.

You will most likely ovulate within 5 to 10 days after you take clomiphene. To improve your chance of becoming pregnant, you should have sexual intercourse while you are ovulating.

Your doctor may have you take your temperature each morning and record your daily readings on a chart. This will help you determine when you can expect ovulation to occur.

In most cases, clomiphene should not be used for more than 3 treatment cycles.

If ovulation occurs but you do not get pregnant after 3 treatment cycles, your doctor may stop treatment and evaluate your infertility further.

Store at room temperature away from moisture, heat, and light.

What happens if I miss a dose?

Call your doctor for instructions if you miss a dose of clomiphene.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid?

This medication may cause blurred vision. Be careful if you drive or do anything that requires you to be alert and able to see clearly.

Clomiphene side effects

Get emergency medical help if you have any signs of an allergic reaction to clomiphene: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Some women using this medicine develop a condition called ovarian hyperstimulation syndrome (OHSS), especially after the first treatment. OHSS can be a life threatening condition. Call your doctor right away if you have any of the following symptoms of OHSS:

stomach pain, bloating;
nausea, vomiting, diarrhea;
rapid weight gain, especially in your face and midsection;
little or no urinating; or
pain when you breathe, rapid heart rate, feeling short of breath (especially when lying down).
Stop using clomiphene and call your doctor at once if you have:
pelvic pain or pressure, enlargement in your pelvic area;
vision problems;
seeing flashes of light or floaters in your vision;
increased sensitivity of your eyes to light; or
heavy vaginal bleeding.
Common clomiphene side effects may include:
flushing (warmth, redness, or tingly feeling);
breast pain or tenderness;
headache; or

breakthrough bleeding or spotting.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

For the Consumer

Applies to clomiphene: oral tablet

In addition to its needed effects, some unwanted effects may be caused by clomiphene. In the event that any of these side effects do occur, they may require medical attention.

You should check with your doctor immediately if any of these side effects occur when taking clomiphene:

More common
Bloating

stomach or pelvic pain

If any of the following side effects occur while taking clomiphene, check with your doctor or nurse as soon as possible:

Less common or rare
Blurred vision
decreased or double vision or other vision problems
seeing flashes of light
sensitivity of eyes to light

yellow eyes or skin

Some of the side effects that can occur with clomiphene may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:

More common
Hot flashes
Less common or rare
Breast discomfort
dizziness or lightheadedness
headache
heavy menstrual periods or bleeding between periods
mental depression
nausea or vomiting
nervousness
restlessness
tiredness
trouble in sleeping
For Healthcare Professionals
Applies to clomiphene: compounding powder, oral tablet

General

At recommended dosages, clomiphene is generally well tolerated. Adverse reactions usually are mild, transient, and resolve when clomiphene is discontinued.

Genitourinary

Male sterility after high dose therapy may be due to hyalinization of the tubular membranes and damage to the spermatids. In general, clomiphene enhances spermatozoal motility and does not change the sperm to abnormal or immature forms.

Very common (10% or more): Ovarian enlargement, ovarian hyperstimulation syndrome

Common (1% to 10%): Abnormal uterine bleeding (intermenstrual spotting, menorrhagia), multiple pregnancies, spontaneous abortions (ectopic pregnancies, hydatiform moles, fetus papyraceous)

Uncommon (0.1% to 1%): Stillbirths, increased urinary frequency/volume, vaginal dryness, priapism

Frequency not reported: Temporary sterility in males

Postmarketing reports: Endometriosis, ovarian cyst, ovarian hemorrhage, tubal pregnancy, uterine hemorrhage

Ocular

Common (1% to 10%): Blurred vision, lights, floaters, waves, unspecified visual complaints, photophobia, diplopia, scotomata, phosphenes

Frequency not reported: Scintillations, heat waves, irreversible palinopsia (prolonged afterimages), shimmering of the peripheral field

Postmarketing reports: Abnormal accommodation, cataract, eye pain, macular edema, optic neuritis, photopsia, posterior vitreous detachment, retinal hemorrhage, retinal thrombosis, retinal vascular spasm, temporary or prolonged loss of vision, possibly irreversible

Cardiovascular

Very common (10% or more): Vasomotor flushes

Postmarketing reports: Arrhythmias, chest pain, edema, hypertension, palpitations, phlebitis, pulmonary embolism, shortness of breath, tachycardia, thrombophlebitis.

Endocrine

Frequency not reported: Gynecomastia, thyroid disorders

Postmarketing reports: Thyroid disorders

Oncologic

Uncommon (0.1% to 1%): Leydig cell tumor of testis (in male treated for oligospermia)

Frequency not reported: Ovarian cancer, increased risk of borderline or invasive ovarian tumor

Postmarketing reports: Hepatic hemangiosarcoma, liver cell adenoma, hepatocellular carcinoma, fibrocystic disease, breast carcinoma, endometrial carcinoma, astrocytoma, pituitary tumor, prolactinoma, neurofibromatosis, glioblastoma multiforme, brain abscess, luteoma of pregnancy, dermoid cyst of the ovary, ovarian carcinoma, hydatiform mole, choriocarcinoma, melanoma, myeloma, perianal cysts, renal cell carcinoma, Hodgkin’s lymphoma, tongue carcinoma, bladder carcinoma

Nervous system

Common (1% to 10%): Headache

Uncommon (0.1% to 1%): Dizziness, insomnia, light-headedness, nervous tension, vertigo

Postmarketing reports: Migraine headache, paresthesia, seizure, stroke, syncope

Dermatologic

Uncommon (0.1% to 1%): Dermatitis, rash, hair loss, dry hair

Frequency not reported: Reversible alopecia, urticaria, acne, erythema nodosum, erythema multiforme

Postmarketing reports: Acne, allergic reaction, erythema, erythema multiforme, erythema nodosum, hypertrichosis, pruritis, urticaria

Gastrointestinal

Common (1% to 10%): Abdominal-pelvic discomfort/distention/bloating, nausea, vomiting

Uncommon (0.1% to 1%): Acute abdomen, constipation, diarrhea

Hematologic

Uncommon (0.1% to 1%): Deep vein thrombosis

Frequency not reported: Pituitary hemorrhage (with undiagnosed pituitary tumor)

Postmarketing reports: Leukocytosis

A 32-year-old woman receiving clomiphene citrate treatment for ovulation induction was admitted for complaints of swelling and pain in her right calf. Her medical history was unremarkable except for complications following an appendectomy three years prior which resulted in a deep vein thrombosis (DVT) and subsequent pulmonary embolism. The patient had been taking clomiphene two days prior to the development of the first DVT. Six months later, the treatment with clomiphene was renewed. The patient developed recurrent DVT following repeated standard clomiphene treatment.

Hepatic

Postmarketing reports: Increased transaminases, hepatitis

Metabolic

Uncommon (0.1% to 1%): Increased appetite, weight gain/loss

Musculoskeletal

Postmarketing reports: Arthralgia, back pain, myalgia

Other

Common (1% to 10%): Breast discomfort

Uncommon (0.1% to 1%): Fatigue

Frequency not reported: Elevated levels of desmosterol (for prolonged therapy)

Postmarketing reports: Fever, tinnitus, weakness

Fetal/Neonatal Anomalies and Mortality:

Uncommon (0.1% to 1%): Congenital heart lesions, down syndrome, club foot, congenital gut lesions, hypospadias, microcephaly, harelip and cleft palate, congenital hip, hemangioma, undescended testicles, polydactyly, conjoined twins and teratomatous malformation, patent ductus arteriosus, amaurosis, arteriovenous fistula, inguinal hernia, umbilical hernia, syndactyly, pectus excavatum, myopathy, dermoid cyst of scalp, omphalocele, spina bifida occulta, ichthyosis, and persistent lingual frenulum, neonatal death, fetal death/stillbirth

Postmarketing reports: Skeletal malformations of the skull, face, nasal passages, jaw, hand, limb (ectromelia including amelia, hemimelia, and phocomelia), foot (clubfoot), spine, joints; septal heart defects, muscular ventricular septal defect, patent ductus arteriosus, tetralogy of Fallot, coarctation of the aorta; down syndrome; ear abnormalities and deafness; cleft lip and palate, imperforate anus, tracheoesophageal fistula, diaphragmatic hernia, omphalocele; hypospadias, cloacal exstrophy, lung tissue malformations; malformations of the eye and lens (cataract); neuroectodermal tumor, thyroid tumor, hepatoblastoma, lymphocytic leukemia; neural tube defects (anencephaly, meningomyelocele), microcephaly, hydrocephalus; renal agenesis and renal dysgenesis; dwarfism, mental retardation

Applies to the following strength(s): 50 mg

Usual Adult Dose for:

Ovulation Induction
Lactation Suppression
Oligospermia
Additional dosage information:
Renal Dose Adjustments
Liver Dose Adjustments
Dialysis

Usual Adult Dose for Ovulation Induction

50 mg orally once a day for 5 days. Therapy should be initiated on or near the 5th day of the menstrual cycle, but may be started at any time in patients without recent uterine bleeding.

Usual Adult Dose for Lactation Suppression

50 to 100 mg orally once a day for 5 days. Generally, one course of therapy is sufficient.

Usual Adult Dose for Oligospermia

25 to 100 mg orally once a day. Therapy is generally given over a period of several months.

Renal Dose Adjustments

Dosage reductions are not recommended for patients with renal dysfunction during short term clomiphene therapy. Dosage reductions are also not recommended for patients with renal dysfunction during long term clomiphene therapy. However, the half-life of clomiphene may be prolonged with chronic therapy and patients with renal dysfunction should be monitored for patient response and tolerance.